Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.

Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB.

Arch Gen Psychiatry. 1999 May;56(5):407-12.

PMID:
10232294
2.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
3.

Carbamazepine and valproate in the maintenance treatment of bipolar disorder.

Keck PE Jr, McElroy SL.

J Clin Psychiatry. 2002;63 Suppl 10:13-7. Review.

4.

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu CC, Shen WW.

Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71. Erratum in: Eur Neuropsychopharmacol. 2004 Mar;14(2):173.

PMID:
12888186
5.

Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.

Chiu CC, Huang SY, Chen CC, Su KP.

J Clin Psychiatry. 2005 Dec;66(12):1613-4. No abstract available.

PMID:
16401167
6.

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ.

Arch Gen Psychiatry. 2000 May;57(5):481-9.

PMID:
10807488
7.

Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.

Bowden CL, Myers JE, Grossman F, Xie Y.

J Clin Psychiatry. 2004 May;65(5):707-14.

PMID:
15163260
8.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
9.
10.

Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.

Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter TA, Keck PE, Swann A, Kalali A; SPD417 Study Group..

CNS Drugs. 2006;20(3):219-31.

PMID:
16529527
11.

Fish oils and bipolar disorder: a promising but untested treatment.

Calabrese JR, Rapport DJ, Shelton MD.

Arch Gen Psychiatry. 1999 May;56(5):413-4; discussion 415-6. No abstract available.

PMID:
10232295
13.

Quetiapine alone and added to a mood stabilizer for serious mood disorders.

Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR.

J Clin Psychiatry. 2001 Sep;62(9):728-32.

PMID:
11681770
14.

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.

J Affect Disord. 2008 Dec;111(2-3):351-9. doi: 10.1016/j.jad.2008.03.008.

PMID:
18485485
15.

Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.

McElroy SL, Bowden CL, Collins MA, Wozniak PJ, Keck PE Jr, Calabrese JR.

J Affect Disord. 2008 Apr;107(1-3):127-33.

PMID:
17888516
16.

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.

Yatham LN, Paulsson B, Mullen J, Vågerö AM.

J Clin Psychopharmacol. 2004 Dec;24(6):599-606. Erratum in: J Clin Psychopharmacol. 2005 Feb;25(1):103. J Clin Psychopharmacol. 2005 Apr;25(2):201.

PMID:
15538120
17.

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH; SPD417 Study Group..

J Clin Psychiatry. 2005 Mar;66(3):323-30. Erratum in: J Clin Psychiatry. 2005 May;66(5):659.

PMID:
15766298
18.

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.

J Affect Disord. 2008 Aug;109(3):251-63. doi: 10.1016/j.jad.2008.06.001.

PMID:
18579216
19.

Inositol as an add-on treatment for bipolar depression.

Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A, Pollock B, Luther J, Buttenfield J, Verfaille S, Kupfer DJ.

Bipolar Disord. 2000 Mar;2(1):47-55.

PMID:
11254020
20.

Efficacy of omega-3 fatty acid supplementation on improvement of bipolar symptoms: a systematic review.

Turnbull T, Cullen-Drill M, Smaldone A.

Arch Psychiatr Nurs. 2008 Oct;22(5):305-11. doi: 10.1016/j.apnu.2008.02.011. Review.

PMID:
18809123

Supplemental Content

Support Center